Coagulation dysfunction in COVID-19.
10.3785/j.issn.1008-9292.2020.04.03
- Author:
Yiming XU
1
;
Dandan LYU
1
;
Kejing YING
1
Author Information
1. Department of Respiratory Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China.
- Publication Type:Journal Article
- MeSH:
Betacoronavirus;
Blood Coagulation Disorders;
etiology;
Coronavirus Infections;
complications;
Humans;
Pandemics;
Pneumonia, Viral;
complications
- From:
Journal of Zhejiang University. Medical sciences
2020;49(3):340-346
- CountryChina
- Language:Chinese
-
Abstract:
In addition to common clinical features, patients with coronavirus disease 2019 (COVID-19) have varying degree of coagulation dysfunction with the risk of thrombosis and/or bleeding. COVID-19 related coagulation dysfunction is a dynamic process, which may be accompanied by the formation of disseminated intravascular coagulation and is related to the severity of the disease. The imbalance of the body's immune and inflammatory response caused by coronavirus infection is an important cause of coagulation dysfunction. Dynamic monitoring as well as early prevention and treatment are of great significance for improving the prognosis of patients. This article reviews the research progress of COVID-19 related coagulation dysfunction, to provide reference for clinical research and management.
